In a finding that might add weight to industry calls for continued free movement of vital talent post-Brexit, a study has shown that country managers and European heads in UK pharma are far more internationally diverse than their French and German counterparts.
New research published by Heidrick & Struggles (Nasdaq: HSII), a leading provider of executive search, leadership consulting and culture shaping worldwide, shows that, in stark contrast to France, where only 7% of these execs have international backgrounds, almost three-quarters (70%) of those in the UK come from outside the UK. In Germany, a third of senior roles are held by non-German nationals.
"In general, hiring trends remain too conservative"
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze